Afficher la notice abrégée

dc.contributor.editorBerend, Olivier
dc.date.accessioned2021-04-20T16:03:13Z
dc.date.available2021-04-20T16:03:13Z
dc.date.issued2019
dc.identifierONIX_20210420_9781789852776_2460
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/67101
dc.description.abstractMajor depression is a severe and prevalent brain disorder with a high disability burden, hence the push for effective treatments. Antidepressants have been around since the 1950s, and although current medications are much more effective than early ones, there is still much room for improvement. "Real" antidepressants, defined as those that "repair" or "improve" the depression-causing mechanism in the brains of depressed patients, have yet to be identified. This book presents current research on depression and antidepressants, including use of antidepressants in alcohol use disorders and pregnancy, treatment-resistant depression, and development of potential new medications.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.otherPharmacology
dc.titleAntidepressants
dc.title.alternativePreclinical, Clinical and Translational Aspects
dc.typebook
oapen.identifier.doi10.5772/intechopen.73911
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9781789852776
oapen.relation.isbn9781789852660
oapen.relation.isbn9781789852783
oapen.imprintIntechOpen
oapen.pages124


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/